Scarica l'app Stockscreener
0.4664
2.63%
-0.0126
Vivos Therapeutics Inc Borsa (VVOS) Ultime notizie
Vivos Therapeutics Announces Securities Purchase Agreement and Registration Rights for PIPE Financing - Minichart
Vivos Therapeutics Creates New Series A Preferred Stock - TipRanks
Vivos Therapeutics Raises $2.1 Million in PIPE With V-Co 4 and Bigger Capital - TradingView
Vivos Therapeutics (VVOS) completes $2.1M PIPE with preferred stock and warrants - Stock Titan
Enterprise value to EBITDA forward of Vivos Therapeutics, Inc. – NASDAQ:VVOS - TradingView
VVOSVivos Therapeutics Inc Latest SEC Filings - Finviz
Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants - The Manila Times
Vivos says its Vida appliance improved insomnia in all 37 patients - Stock Titan
VIVOS THERAPEUTICS INC (VVOS) Stock Chart - ChartMill
Vivos Therapeutics, Inc. Actuals & Estimates (NASDAQ:VVOS) - TradingView
Vivos Therapeutics Extends Debt-for-Equity Conversion Timeline - TipRanks
Vivos (NASDAQ: VVOS) extends Streeterville $4.5M debt-for-equity pact - Stock Titan
Vivos Therapeutics Enters Debt-for-Equity Deal, Extends $2.6M Financing Deadline With Streeterville - TradingView
VVOS Forecast — Price Target — Prediction for 2027 - TradingView
Vivos Therapeutics Inc (VVOS) Institutional Confidence - TradingKey
VVOS Q1 2026 Earnings: EPS Misses Estimates as Stock Surges on Operational ProgressEarnings Revision Upgrade - dars.gov.et
Vivos extends debt conversion deadline with Streeterville to August - Investing.com UK
Vivos extends debt conversion deadline with Streeterville to August By Investing.com - Investing.com Australia
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity - marketscreener.com
Vivos Therapeutics Inc (VVOS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vivos Therapeutics Inc (VVOS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vivos Therapeutics Inc (VVOS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivos Therapeutics Inc (VVOS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vivos Therapeutics Inc (VVOS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vivos Therapeutics Inc (VVOS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivos Therapeutics Inc (VVOS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivos Therapeutics (VVOS) Slides 6% as Selling Pressure Intensifies Near Key SupportForce Index - dars.gov.et
Vivos Therapeutics Plans Rights Offering to Existing Shareholders - TipRanks
Vivos Therapeutics (NASDAQ: VVOS) outlines proposed tradable rights offering terms - Stock Titan
Vivos Therapeutics Partners with Florida Cardiology Group to Expand Sleep Apnea and Insomnia Treatment for Cardiovascular Patients – Minichart - Minichart
Vivos Therapeutics Forms AIM Florida Sleep Care Venture - TipRanks
Vivos Therapeutics (NASDAQ: VVOS) inks AIM Florida deal with major cardiology group - Stock Titan
Vivos Therapeutics Inc. (VVOS) Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesLong-Term Guidance - lwvtexas.org
Vivos Therapeutics Plans to File for Proposed Rights Offering - Moomoo
Vivos Therapeutics plans rights offering for shareholders By Investing.com - Investing.com South Africa
Vivos Therapeutics plans rights offering for shareholders - Investing.com
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering - The Manila Times
Vivos plans 9‑month tradable rights for shareholders to buy stock - Stock Titan
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients - The Manila Times
VVOS: Capital-light, scalable sleep apnea treatment model targets rapid, profitable national expansion - TradingView
VVOS: Rapidly scaling sleep apnea treatment with high margins and unique FDA-cleared devices - TradingView
Vivos Therapeutics Restructures Debt to Support Nasdaq Compliance - The Globe and Mail
Vivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026 - Quiver Quantitative
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 - The Manila Times
Vivos Therapeutics Announces $4.5 Million Debt-to-Equity Exchange Agreement to Support Nasdaq Listing and Strengthen Financial Position – Minichart - Minichart
Vivos Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
[8-K] Vivos Therapeutics, Inc. Reports Material Event - Stock Titan
Vivos Therapeutics agrees to debt-to-equity exchange with lender By Investing.com - Investing.com South Africa
6/5/2026 Market UpdateWinners: NOTV, STI, BGMSLosers: BIGGQ, NUWE, CYPHS&P 500: -2.6% - Trefis
Vivos Therapeutics Shares Surge After $4.5 Million Debt Conversion Fuels Nasdaq Optimism - TechStock²
Vivos Therapeutics (VVOS) Stock: Debt Exchange Plan Fuels Investor Optimism - parameter.io
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):